Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. SOLA Pharmaceuticals LLC
FDA Inspection
•SOLA Pharmaceuticals LLC•December 18, 2024

SOLA Pharmaceuticals LLC – FDA Inspection, Dec 18, 2024

Record Details

This FDA Inspection record concerns SOLA Pharmaceuticals LLC, with an inspection on December 18, 2024, issued by the New Orleans District Office, covering human drugs.

Company
SOLA Pharmaceuticals LLC
Inspection Date
December 18, 2024
Product Type
Human Drugs
Office
New Orleans District Office
People
  • Mercedes N. Overton (Issuing Officer)
  • Milton J. De Jesus Tavarez (Issuing Officer)
  • Ronda R. Lloyd-Jones (FDA Associated Person)
View Company Profile

ID · c213fd93-f106-499a-806f-ef3b23614b3d

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1256965
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

2
  1. 21 CFR 211.22(a)Lack of quality control unit
  2. 21 CFR 211.22(d)Procedures not in writing, fully followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of SOLA Pharmaceuticals LLC

2
DateClassificationOfficeProject area
January 8, 2025NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
March 22, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for SOLA Pharmaceuticals LLC
  • FDA Inspection 1258442 - 2025-01-08
  • FDA Inspection 1088275 - 2019-03-22

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SOLA Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.